Impact of robotics on the outcome of elderly patients with endometrial cancer

Robotic vs Open Surgery for Endometrial Cancer in Elderly Patients: Surgical Outcome, Survival, and Cost Analysis

“…Operating time has previously been reported to be longer for robotic surgery in the general population, 20 and Lavoue et al, 46 showed data in the same direction for the elderly reporting OT of 244.2 and 217.7 minutes (P = 0.009) in the robotic and open surgery groups, respectively. In our study, the robotic OT was similar to that of open surgery, and only 105 vs 107 minutes (P G 0.704).…”

“…45 Even in this elderly population, surgical outcomes concerning EBL and LOS were in favor of robotic surgery and in line with what has previously been described; this should be considered of great importance with regard to the fragile elderly cohort, where minimizing postoperative morbidity may be crucial. 22,23,25,46,47 In total, one may consider the evidence in favor of robotic surgery concerning EBL and LOS convincing also in elderly women diagnosed as having endometrial cancer. Early ambulation and return to home are not only favorable in terms of costs but also, and more importantly, of special advantage for elderly women and their risk for further complications.…”

Robotic Surgery in the Management of Endometrial Cancer

“…The operative time was increased for the laparoscopic group, however, there was no increased morbidity from longer anesthetic times. [70] Another study by Lavoue et al [87] compared a population (n = 113) of advanced age patients (greater than or equal to 70 years) with endometrial cancer undergoing surgical staging by either robotic or traditional open surgery. The robotic group had longer operating times (244 vs 217 min, p = 0.009) but less estimated mean EBL (75 vs 334 mL, p < 0.0001), less minor adverse events (17 vs 60%, p < 0.001) and decreased mean LOHS (3 vs 6 days, p < 0.0001).…”

Lack of improvement in survival rates for women under 50 with endometrial cancer, 2000–2011

“…Research has shown that survival decreases with increasing age at diagnosis, with survival worse in patients over age 50 (Farley et al 2000). Previous studies have focused on older age groups, and more study is needed among younger women (AlHilli et al 2015;De Marzi et al 2013;Lavoue et al 2014). Treatment for endometrial cancer may be selected as a result of risk factors, e.g., age, body mass index, comorbidities.…”